10hon MSN
A Scottish woman has the remarkable ability to smell Parkinson’s disease years before symptoms appear. With her help, ...
After being diagnosed with Parkinson’s disease at just 50 years old, Tammy Corrigan turned to exercise to help manage her ...
Cerevance has said it plans to move on to late-stage trials of its first-in-class Parkinson's disease drug CVN424 after hitting the mark in a phase 2 proof-of-concept study. The Boston-based ...
With over 10 million people affected worldwide, Parkinson's disease is the fastest-growing neurological disorder. More than ...
Annovis Bio Inc. (NYSE: ANVS) ("Annovis"), a late-stage clinical drug platform company pioneering transformative therapies ...
MeiraGTx (Nasdaq: MGTX) has entered into a strategic partnership with artificial intelligence firm Hologen to accelerate the ...
March 11, 2025 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE: ANVS) ("Annovis"), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results